{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:25:50Z","timestamp":1773321950658,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.imlet.2006.03.007","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T17:42:46Z","timestamp":1145468566000},"page":"19-26","source":"Crossref","is-referenced-by-count":14,"title":["Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma"],"prefix":"10.1016","volume":"106","author":[{"given":"Tae-Hyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Doo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Ick","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Lan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Geol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2006.03.007_bib1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0039-6109(05)70511-9","article-title":"Epidemiology of malignant melanoma","volume":"76","author":"Liu","year":"1996","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.imlet.2006.03.007_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1040-8428(02)00077-X","article-title":"Malignant melanoma","volume":"47","author":"de Braud","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.imlet.2006.03.007_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2006.03.007_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/107327480200900104","article-title":"Immunotherapy for melanoma","volume":"9","author":"Kim","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.imlet.2006.03.007_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00262-003-0468-6","article-title":"Dendritic cell biology and cancer therapy","volume":"53","author":"Whiteside","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.imlet.2006.03.007_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0046-8177(97)90079-4","article-title":"Physiology and pathophysiology of dendritic cells","volume":"28","author":"Wright-Browne","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.imlet.2006.03.007_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ijc.1365","article-title":"Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic\/necrotic tumor cells","volume":"93","author":"Chen","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.imlet.2006.03.007_bib8","first-page":"1331","article-title":"A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen","volume":"5","author":"Morse","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.imlet.2006.03.007_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2006.03.007_bib10","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1097\/01.ju.0000144211.51111.e4","article-title":"Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer","volume":"172","author":"Ragde","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.imlet.2006.03.007_bib11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V99.5.1517","article-title":"Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients","volume":"99","author":"Timmerman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2006.03.007_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/sonc.2002.35243","article-title":"Melanoma vaccines","volume":"29","author":"Minev","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.imlet.2006.03.007_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00262-002-0280-8","article-title":"Immature myeloid cells and cancer-associated immune suppression","volume":"51","author":"Kusmartsev","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.imlet.2006.03.007_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/IR:23:2-3:263","article-title":"VEGF as a mediator of tumor-associated immunodeficiency","volume":"23","author":"Ohm","year":"2001","journal-title":"Immunol Res"},{"key":"10.1016\/j.imlet.2006.03.007_bib15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.160.3.1224","article-title":"Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells","volume":"160","author":"Oyama","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2006.03.007_bib16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrc1167","article-title":"Adoptive-cell-transfer therapy for the treatment of patients with cancer","volume":"3","author":"Dudley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.imlet.2006.03.007_bib17","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1200\/JCO.2004.10.041","article-title":"Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance","volume":"22","author":"Mapara","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.imlet.2006.03.007_bib18","first-page":"2802","article-title":"Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity","volume":"59","author":"Melcher","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.imlet.2006.03.007_bib19","first-page":"1755","article-title":"Clinical significance of defective dendritic cell differentiation in cancer","volume":"6","author":"Almand","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.imlet.2006.03.007_bib20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4049\/jimmunol.164.3.1269","article-title":"Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells","volume":"164","author":"Kiertscher","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2006.03.007_bib21","first-page":"97","article-title":"Escape mechanisms in tumor immunity: a year 2000 update","volume":"11","author":"Pawelec","year":"2000","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.imlet.2006.03.007_bib22","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2174\/1381612023394089","article-title":"Immune modulation by ionizing radiation and its implications for cancer immunotherapy","volume":"8","author":"Friedman","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.imlet.2006.03.007_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-8140(84)80074-2","article-title":"The radioresponsiveness of human tumours and the initial slope of the cell survival curve","volume":"2","author":"Deacon","year":"1984","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.imlet.2006.03.007_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1097-0142(19880115)61:2<243::AID-CNCR2820610207>3.0.CO;2-K","article-title":"Analysis of dose fractionation in the palliation of metastases from malignant melanoma","volume":"61","author":"Konefal","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.imlet.2006.03.007_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0167-8140(94)90067-1","article-title":"Fractionation sensitivity (alpha\/beta ratio) of human melanoma xenografts","volume":"33","author":"Rofstad","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.imlet.2006.03.007_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0733-8635(02)00029-3","article-title":"Radiation therapy of malignant melanoma","volume":"20","author":"Cooper","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.imlet.2006.03.007_bib27","first-page":"759","article-title":"Malignant melanoma: the role of radiation therapy revisited","volume":"23","author":"Jenrette","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.imlet.2006.03.007_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0360-3016(91)90053-7","article-title":"Fraction size in external beam radiation therapy in the treatment of melanoma","volume":"20","author":"Sause","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.imlet.2006.03.007_bib29","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<980::AID-CNCR28>3.0.CO;2-H","article-title":"An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases","volume":"85","author":"Firusian","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.imlet.2006.03.007_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s002590000380","article-title":"The potential of intratumoural unsealed radioactive source therapy","volume":"28","author":"McCready","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.imlet.2006.03.007_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00259-001-0696-y","article-title":"Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide","volume":"29","author":"Lee","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.imlet.2006.03.007_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/1097-0215(20011215)94:6<825::AID-IJC1545>3.0.CO;2-5","article-title":"Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: approach to treatment of advanced stage cancer","volume":"94","author":"Nikitina","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.imlet.2006.03.007_bib33","first-page":"8466","article-title":"Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration","volume":"63","author":"Teitz-Tennenbaum","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.imlet.2006.03.007_bib34","first-page":"399","article-title":"Biologic basis for radiation oncology","volume":"10","author":"Coleman","year":"1996","journal-title":"Oncology"},{"key":"10.1016\/j.imlet.2006.03.007_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.it.2003.09.007","article-title":"NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity","volume":"24","author":"Albertsson","year":"2003","journal-title":"Trends Immunol"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247806000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247806000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T04:07:10Z","timestamp":1683432430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247806000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0165247806000952"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2006.03.007","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}